Portfolio (Quarterly)
Guide ↗
Patient Square Capital LP
· CIK 0001819257| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 8,020,928.0 | $283.9M | 43.97% | NEW | — | $35.39 | +5.6% |
| 2 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 276,000.0 | $51.7M | 8.01% | NEW | — | $187.28 | +15.3% |
| 3 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 260,500.0 | $30.5M | 4.72% | NEW | — | $117.07 | -13.8% |
| 4 | ABVX | ABIVAX SA | Healthcare | 206,500.0 | $27.5M | 4.26% | NEW | — | $133.26 | -10.7% |
| 5 | — | BEONE MEDICINES LTD | — | 90,020.0 | $25.7M | 3.97% | NEW | — | $284.97 | — |
| 6 | PHVS | PHARVARIS N V | Healthcare | 671,209.0 | $23.2M | 3.60% | NEW | — | $34.58 | +4.4% |
| 7 | ARGX | ARGENX SE | Healthcare | 23,000.0 | $21.3M | 3.31% | NEW | — | $927.77 | +7.0% |
| 8 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 37,120.0 | $20.1M | 3.12% | NEW | — | $541.83 | -4.3% |
| 9 | BLTE | BELITE BIO INC | Healthcare | 110,000.0 | $16.9M | 2.62% | NEW | — | $153.99 | +5.6% |
| 10 | COGT | COGENT BIOSCIENCES INC | Healthcare | 425,000.0 | $16.4M | 2.55% | NEW | — | $38.70 | -3.4% |
| 11 | — | DBV TECHNOLOGIES S A | — | 909,474.0 | $14.9M | 2.31% | NEW | — | $16.40 | — |
| 12 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 220,000.0 | $13.3M | 2.06% | NEW | — | $60.36 | +4.7% |
| 13 | BNTX | BIONTECH SE | Healthcare | 134,429.0 | $12.5M | 1.94% | NEW | — | $93.05 | -0.3% |
| 14 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 355,800.0 | $11.0M | 1.70% | NEW | — | $30.83 | -4.3% |
| 15 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 212,500.0 | $10.8M | 1.67% | NEW | — | $50.75 | +18.4% |
| 16 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 108,000.0 | $10.5M | 1.63% | NEW | — | $97.48 | +18.5% |
| 17 | ALLO | ALLOGENE THERAPEUTICS INC | Healthcare | 5,050,000.0 | $10.5M | 1.63% | NEW | — | $2.08 | -2.4% |
| 18 | EYPT | EYEPOINT INC | Healthcare | 720,000.0 | $10.3M | 1.59% | NEW | — | $14.30 | -61.7% |
| 19 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 370,000.0 | $9.7M | 1.50% | NEW | — | $26.22 | +1.2% |
| 20 | CCCC | C4 THERAPEUTICS INC | Healthcare | 1,608,815.0 | $7.5M | 1.16% | NEW | — | $4.67 | -10.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%